Influence of tumor volume on survival in patients with oral squamous cell carcinoma
- 321 Downloads
The TNM classification is used to assess cancers of the oral cavity, and advancements in imaging techniques have revealed clear variations in tumor volume at presentation. This study therefore aimed to clarify whether preoperative imaging, with exact measurements of the tumor, could affect post-surgery survival after controlling for demographic, clinical, and tumor characteristics.
We included 437 patients with histologically confirmed, stage T1–4, N1–3, M0, invasive squamous cell carcinoma of the tongue. Participants were assessed for recurrence every 3 months for the first 2 years, every 6 months for another 2 years, and annually thereafter; routine computed tomography was performed annually. Associations were determined using the Kaplan–Meier estimator, univariate log-rank test, and Cox proportional hazards regression models.
The mean survival of all patients was 68.1 ± 48.2 months. The 2- and 5-year overall survival rates were 82.2 and 66.7 %, respectively. The mean primary tumor volume was 7.14 cm3 with a range of 1.3–24.21 cm3. The ROC curve and Youden Index analysis revealed that the optimal cutoff volume was between ≤5.9 and ≤18.3 cm3 for three different volume groups (p < 0.0001). Large tumor volume was associated with a significantly poorer overall survival (p < 0.0001).
Tumor volume was significantly associated with the overall survival of patients. This has both prognostic and reconstructive implications that will affect health-related quality of life. In addition, this will inform surgical planning and the allocation of resources.
KeywordsTNM classification Oral squamous cell carcinoma of the tongue Tumor volume Reconstructive surgery
All persons who have contributed to the study are listed as co-authors. The study was not funded.
Conflict of interest
We declare that we have no conflict of interest.
- Brown L, Rieger JM, Harris J, Seikaly H (2010) A longitudinal study of functional outcomes after surgical resection and microvascular reconstruction for oral cancer: tongue mobility and swallowing function. J Oral Maxillofac Surg 68(11):2690–2700. doi: 10.1016/j.joms.2010.05.004 CrossRefPubMedGoogle Scholar
- Expert Panel on Radiation O-H and Neck, Salama JK, Saba N, Quon H, Garg MK, Lawson J, McDonald MW, Ridge JA, Smith RV, Yeung AR, Yom SS, Beitler JJ (2011) ACR appropriateness criteria® adjuvant therapy for resected squamous cell carcinoma of the head and neck. Oral oncology 47(7):554–559. doi: 10.1016/j.oraloncology.2011.05.002 CrossRefGoogle Scholar
- Kreppel M, Dreiseidler T, Rothamel D, Eich HT, Drebber U, Zoller JE, Scheer M (2013) The role of clinical versus histopathological staging in patients with advanced oral squamous cell carcinoma treated with neoadjuvant radiochemotherapy followed by radical surgery. J cranio-maxillo-facial surgery 41(1):22–27. doi: 10.1016/j.jcms.2012.05.005 CrossRefGoogle Scholar
- Matsui Y, Ohno K, Yamashita Y, Takahashi K (2007) Factors influencing postoperative speech function of tongue cancer patients following reconstruction with fasciocutaneous/myocutaneous flaps—a multicenter study. Int J Oral Maxillofac Surg 36(7):601–609. doi: 10.1016/j.ijom.2007.01.014 CrossRefPubMedGoogle Scholar
- Oliveira LR, Ribeiro-Silva A, Costa JP, Simoes AL, Matteo MA, Zucoloto S (2008) Prognostic factors and survival analysis in a sample of oral squamous cell carcinoma patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 106(5):685–695. doi: 10.1016/j.tripleo.2008.07.002 CrossRefPubMedGoogle Scholar
- Pignon JP, Bourhis J, Domenge C, Designe L (2000) Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of chemotherapy on head and neck cancer. Lancet 355(9208):949–955CrossRefPubMedGoogle Scholar
- Poulsen MG, Denham JW, Peters LJ, Lamb DS, Spry NA, Hindley A, Krawitz H, Hamilton C, Keller J, Tripcony L, Walker Q (2001) A randomised trial of accelerated and conventional radiotherapy for stage III and IV squamous carcinoma of the head and neck: a Trans-Tasman Radiation Oncology Group Study. Radiother Oncol 60(2):113–122CrossRefPubMedGoogle Scholar
- Vergez S, Moriniere S, Dubrulle F, Salaun PY, De Mones E, Bertolus C, Temam S, Chevalier D, Lagarde F, Schultz P, Ferrie JC, Badoual C, Lapeyre M, Righini C, Barry B, Tronche S, De Raucourt D, SFORL (2013) Initial staging of squamous cell carcinoma of the oral cavity, larynx and pharynx (excluding nasopharynx) Part I: Locoregional extension assessment: 2012 SFORL guidelines. Eur Ann Otorhinolaryngol Head Neck Dis 130(1):39–45. doi: 10.1016/j.anorl.2012.09.004 CrossRefPubMedGoogle Scholar